Display options
Cite
Ratajczak MZ, Kucia M. Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship. Leukemia. 2021;doi: 10.1038/s41375-021-01482-0.
Ratajczak, M. Z., & Kucia, M. (2021). Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship. Leukemia, . https://doi.org/10.1038/s41375-021-01482-0
Ratajczak, Mariusz Z, and Kucia, Magdalena. "Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship." Leukemia vol. (2021). doi: https://doi.org/10.1038/s41375-021-01482-0
Ratajczak MZ, Kucia M. Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship. Leukemia. 2021 Dec 01; doi: 10.1038/s41375-021-01482-0. Epub 2021 Dec 01. PMID: 34853440.
Copy Download .nbib Format: NLM
Share it on

Leukemia. 2021 Dec 01; doi: 10.1038/s41375-021-01482-0. Epub 2021 Dec 01.

Hematopoiesis and innate immunity: an inseparable couple for good and bad times, bound together by an hormetic relationship.

Leukemia

Mariusz Z Ratajczak, Magdalena Kucia

Affiliations

  1. Stem Cell Institute at Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA. [email protected].
  2. Laboratory of Regenerative Medicine Medical University of Warsaw, Warsaw, Poland. [email protected].
  3. Stem Cell Institute at Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA. [email protected].
  4. Laboratory of Regenerative Medicine Medical University of Warsaw, Warsaw, Poland. [email protected].

PMID: 34853440 DOI: 10.1038/s41375-021-01482-0

Abstract

Hematopoietic and immune cells originate from a common hematopoietic/lymphopoietic stem cell what explains that these different cell types often share the same receptors and respond to similar factors. Moreover, the common goal of both lineages is to ensure tissue homeostasis under steady-state conditions, fight invading pathogens, and promote tissue repair. We will highlight accumulating evidence that innate and adaptive immunity modulate several aspects of hematopoiesis within the hormetic zone in which the biological response to low exposure to potential stressors generally is favorable and benefits hematopoietic stem/progenitor cells (HSPCs). Innate immunity impact on hematopoiesis is pleiotropic and involves both the cellular arm, comprised of innate immunity cells, and the soluble arm, whose major component is the complement cascade (ComC). In addition, several mediators released by innate immunity cells, including inflammatory cytokines and small antimicrobial cationic peptides, affect hematopoiesis. There are intriguing observations that HSPCs and immune cells share several cell-surface pattern-recognition receptors (PRRs), such as Toll-like receptors (TLRs) and cytosol-expressed NOD, NOD-like, and RIG-I-like receptors and thus can be considered "pathogen sensors". In addition, not only lymphocytes but also HSPCs express functional intracellular complement proteins, defined as complosome which poses challenging questions for further investigation of the intracellular ComC-mediated intracrine regulation of hematopoiesis.

© 2021. The Author(s).

References

  1. Dzierzak E, Bigas A. Blood development: hematopoietic stem cell dependence and independence. Cell Stem Cell. 2018;22:639–51. - PubMed
  2. Ling KW, Dzierzak E. Ontogeny and genetics of the hemato/lymphopoietic system. Curr Opin Immunol. 2002;14:186–91. - PubMed
  3. Capitano ML. Toll-like receptor signaling in hematopoietic stem and progenitor cells. Curr Opin Hematol. 2019;26:207–13. - PubMed
  4. Ratajczak MZ, Kucia M. The Nlrp3 inflammasome - the evolving story of its positive and negative effects on hematopoiesis. Curr Opin Hematol. 2021;28:251–61. - PubMed
  5. Boettcher S, Manz MG. Regulation of inflammation and infection-driven hematopoiesis. Trends Immunol. 2017;38:345–57. - PubMed
  6. Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805–20. - PubMed
  7. Luo H, Mu WC, Karki R, Chiang HH, Mohrin M, Shin JJ, et al. Mitochondrial stress-initiated aberrant activation of the NLRP3 inflammasome regulates the functional deterioration of hematopoietic stem cell aging. Cell Rep. 2019;26:945–54. - PubMed
  8. Ratajczak MZ, Bujko K, Cymer M, Thapa A, Adamiak M, Ratajczak J, et al. The Nlrp3 inflammasome as a “rising star” in studies of normal and malignant hematopoiesis. Leukemia 2020;34:1512–23. - PubMed
  9. Croker BA, Silke J, Gerlic M. Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis. Curr Opin Hematol. 2015;22:293–301. - PubMed
  10. Jaiswal S. Clonal hematopoiesis and nonhematologic disorders. Blood 2020;136:1606–14. - PubMed
  11. Lussana F, Rambaldi A. Inflammation and myeloproliferative neoplasms. J Autoimmun. 2017;85:58–63. - PubMed
  12. Stenzinger M, Karpova D, Unterrainer C, Harenkamp S, Wiercinska E, Hoerster K, et al. Hematopoietic-extrinsic cues dictate circadian redistribution of mature and immature hematopoietic cells in blood and spleen. Cells 2019;8:103. - PubMed
  13. Karpova D, Rettig MP, DiPersio JF. Mobilized peripheral blood: an updated perspective. F1000Res. 2019;8:F1000. - PubMed
  14. Pelus LM, Broxmeyer HE. Peripheral blood stem cell mobilization; a look ahead. Curr Stem Cell Rep. 2018;4:273–81. - PubMed
  15. West EE, Kunz N, Kemper C. Complement and human T cell metabolism: location, location, location. Immunol Rev. 2020;295:68–81. - PubMed
  16. Arbore G, Kemper C, Kolev M. Intracellular complement - the complosome - in immune cell regulation. Mol Immunol. 2017;89:2–9. - PubMed
  17. Rahman J, Singh P, Merle NS, Niyonzima N, Kemper C. Complement’s favourite organelle-mitochondria? Br J Pharm. 2021;178:2771–85. - PubMed
  18. Kunz N, Kemper C. Complement has brains-do intracellular complement and immunometabolism cooperate in tissue homeostasis and behavior? Front Immunol. 2021;12:629986. - PubMed
  19. Hajishengallis G, Reis ES, Mastellos DC, Ricklin D, Lambris JD. Novel mechanisms and functions of complement. Nat Immunol. 2017;18:1288–98. - PubMed
  20. Reis ES, Mastellos DC, Hajishengallis G, Lambris JD. New insights into the immune functions of complement. Nat Rev Immunol. 2019;19:503–16. - PubMed
  21. Huber-Lang M, Lambris JD, Ward PA. Innate immune responses to trauma. Nat Immunol. 2018;19:327–41. - PubMed
  22. Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate lymphoid cells: 10 years on. Cell 2018;174:1054–66. - PubMed
  23. Thapa A, Adamiak M, Bujko K, Ratajczak J, Abdel-Latif AK, Kucia M, et al. Danger-associated molecular pattern molecules take unexpectedly a central stage in Nlrp3 inflammasome-caspase-1-mediated trafficking of hematopoietic stem/progenitor cells. Leukemia 2021;35:2658–71. - PubMed
  24. Budkowska M, Ostrycharz E, Wojtowicz A, Marcinowska Z, Woźniak J, Ratajczak MZ, et al. A circadian rhythm in both complement cascade (ComC) activation and sphingosine-1-phosphate (S1P) levels in human peripheral blood supports a role for the ComC-S1P axis in circadian changes in the number of stem cells circulating in peripheral blood. Stem Cell Rev Rep. 2018;14:677–85. - PubMed
  25. Adamiak M, Ciechanowicz A, Skoda M, Cymer M, Tracz M, Xu B, et al. Novel evidence that purinergic signaling - Nlrp3 inflammasome axis regulates circadian rhythm of hematopoietic stem/progenitor cells circulation in peripheral blood. Stem Cell Rev Rep. 2020;16:335–43. - PubMed
  26. Borkowska S, Suszynska M, Mierzejewska K, Ismail A, Budkowska M, Salata D, et al. Novel evidence that crosstalk between the complement, coagulation and fibrinolysis proteolytic cascades is involved in mobilization of hematopoietic stem/progenitor cells (HSPCs). Leukemia 2014;28:2148–54. - PubMed
  27. Borkowska S, Suszynska M, Ratajczak J, Ratajczak MZ. Evidence of a pivotal role for the distal part of the complement cascade in the diurnal release of hematopoietic stem cells Into peripheral blood. Cell Transpl. 2016;25:275–82. - PubMed
  28. Adamiak M, Abdel-Latif A, Bujko K, Thapa A, Anusz K, Tracz M, et al. Nlrp3 inflammasome signaling regulates the homing and engraftment of hematopoietic stem cells (HSPCs) by enhancing incorporation of CXCR4 receptor into membrane lipid rafts. Stem Cell Rev Rep. 2020;16:954–67. - PubMed
  29. Kim CH, Wu W, Wysoczynski M, Abdel-Latif A, Sunkara M, Morris A, et al. Conditioning for hematopoietic transplantation activates the complement cascade and induces a proteolytic environment in bone marrow: a novel role for bioactive lipids and soluble C5b-C9 as homing factors. Leukemia 2012;26:106–16. - PubMed
  30. Adamiak M, Cymer M, Anusz K, Tracz M, Ratajczak MZ. A novel evidence that mannan binding lectin (MBL) pathway of complement cascade activation is involved in homing and engraftment of hematopoietic stem progenitor cells (HSPCs). Stem Cell Rev Rep. 2020;16:693–701. - PubMed
  31. Wysoczynski M, Reca R, Lee H, Wu W, Ratajczak J, Ratajczak MZ. Defective engraftment of C3aR - PubMed
  32. Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, Franchini S, et al. Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1. Blood 2003;101:3784–93. - PubMed
  33. Ratajczak MZ, Adamiak M, Plonka M, Abdel-Latif A, Ratajczak J. Mobilization of hematopoietic stem cells as a result of innate immunity-mediated sterile inflammation in the bone marrow microenvironment-the involvement of extracellular nucleotides and purinergic signaling. Leukemia 2018;32:1116–23. - PubMed
  34. Cymer M, Brzezniakiewicz-Janus K, Bujko K, Thapa A, Ratajczak J, Anusz K, et al. Pannexin-1 channel “fuels” by releasing ATP from bone marrow cells a state of sterile inflammation required for optimal mobilization and homing of hematopoietic stem cells. Purinergic Signal. 2020;16:313–25. - PubMed
  35. Calabrese EJ. Hormesis: path and progression to significance. Int J Mol Sci. 2018;19:2871. - PubMed
  36. Schirrmacher V. Less can be more: the hormesis theory of stress adaptation in the global biosphere and its implications. Biomedicines 2021;9:293. - PubMed
  37. Woodruff TM, Nandakumar KS, Tedesco F. Inhibiting the C5-C5a receptor axis. Mol Immunol. 2011;48:1631–42. - PubMed
  38. Detsika MG, Duann P, Atsaves V, Papalois A, Lianos EA. Heme oxygenase 1 up-regulates glomerular decay accelerating factor expression and minimizes complement deposition and injury. Am J Pathol. 2016;186:2833–45. - PubMed
  39. Ratajczak MZ, Adamiak M, Ratajczak J, Kucia M. Heme oxygenase 1 (HO-1) as an inhibitor of trafficking of normal and malignant hematopoietic stem cells - clinical and translational implications. Stem Cell Rev Rep. 2021;17:821–8. - PubMed
  40. Detsika MG, Lianos EA. Regulation of complement activation by heme oxygenase-1 (HO-1) in kidney injury. Antioxid. 2021;10:60. - PubMed
  41. Kinderlerer AR, Pombo Gregoire I, Hamdulay SS, Ali F, Steinberg R, Silva G, et al. Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin. Blood 2009;113:1598–607. - PubMed
  42. Schröder-Braunstein J, Kirschfink M. Complement deficiencies and dysregulation: pathophysiological consequences, modern analysis, and clinical management. Mol Immunol. 2019;114:299–311. - PubMed
  43. Liszewski MK, Atkinson JP. Complement regulator CD46: genetic variants and disease associations. Hum Genomics. 2015;9:7. - PubMed
  44. Hayat SMG, Bianconi V, Pirro M, Jaafari MR, Hatamipour M, Sahebkar A. CD47: role in the immune system and application to cancer therapy. Cell Oncol. 2020;43:19–30. - PubMed
  45. Bujko K, Cymer M, Adamiak M, Ratajczak MZ. An overview of novel unconventional mechanisms of hematopoietic development and regulators of hematopoiesis - a roadmap for future investigations. Stem Cell Rev Rep. 2019;15:785–94. - PubMed
  46. Rossi L, Salvestrini V, Ferrari D, Di Virgilio F, Lemoli RM. The sixth sense: hematopoietic stem cells detect danger through purinergic signaling. Blood 2012;120:2365–75. - PubMed
  47. Ratajczak MZ, Lee H, Wysoczynski M, Wan W, Marlicz W, Laughlin MJ, et al. Novel insight into stem cell mobilization-plasma sphingosine-1-phosphate is a major chemoattractant that directs the egress of hematopoietic stem progenitor cells from the bone marrow and its level in peripheral blood increases during mobilization due to activation of complement cascade/membrane attack complex. Leukemia 2010;24:976–85. - PubMed
  48. Golan K, Vagima Y, Ludin A, Itkin T, Cohen-Gur S, Kalinkovich A, et al. S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release. Blood 2012;119:2478–88. - PubMed
  49. Juarez JG, Harun N, Thien M, Welschinger R, Baraz R, Pena AD, et al. Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. Blood 2012;119:707–16. - PubMed
  50. Ratajczak MZ. A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking. Leukemia 2015;29:776–82. - PubMed
  51. Brunstein CG, McKenna DH, DeFor TE, Sumstad D, Paul P, Weisdorf DJ, et al. Complement fragment 3a priming of umbilical cord blood progenitors: safety profile. Biol Blood Marrow Transpl. 2013;19:1474–9. - PubMed
  52. Ratajczak MZ, Kim CH, Abdel-Latif A, Schneider G, Kucia M, Morris AJ, et al. A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients. Leukemia 2012;26:63–72. - PubMed
  53. Ratajczak MZ, Adamiak M. Membrane lipid rafts, master regulators of hematopoietic stem cell retention in bone marrow and their trafficking. Leukemia 2015;29:1452–7. - PubMed
  54. Wu W, Kim CH, Liu R, Kucia M, Marlicz W, Greco N, et al. The bone marrow-expressed antimicrobial cationic peptide LL-37 enhances the responsiveness of hematopoietic stem progenitor cells to an SDF-1 gradient and accelerates their engraftment after transplantation. Leukemia 2012;26:736–45. - PubMed
  55. Bertolotto M, Contini P, Ottonello L, Pende A, Dallegri F, Montecucco F. Neutrophil migration towards C5a and CXCL8 is prevented by non-steroidal anti-inflammatory drugs via inhibition of different pathways. Br J Pharm. 2014;171:3376–93. - PubMed
  56. Lee HM, Wu W, Wysoczynski M, Liu R, Zuba-Surma EK, Kucia M, et al. Impaired mobilization of hematopoietic stem/progenitor cells in C5-deficient mice supports the pivotal involvement of innate immunity in this process and reveals novel promobilization effects of granulocytes. Leukemia 2009;23:2052–62. - PubMed
  57. Yamashita M, Passegué E. TNF-α coordinates hematopoietic stem cell survival and myeloid regeneration. Cell Stem Cell. 2019;25:357–72. - PubMed
  58. Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, et al. IFN alpha activates dormant haematopoietic stem cells in vivo. Nature 2009;458:904–8. - PubMed
  59. Smith JN, Kanwar VS, MacNamara KC. Hematopoietic stem cell regulation by type I and II interferons in the pathogenesis of acquired aplastic anemia. Front Immunol. 2016;7:330. - PubMed
  60. Yazdi AS, Ghoreschi K. The interleukin-1 family. Adv Exp Med Biol. 2016;941:21–29. - PubMed
  61. Frede S, Fandrey J, Pagel H, Hellwig T, Jelkmann W. Erythropoietin gene expression is suppressed after lipopolysaccharide or interleukin-1 beta injections in rats. Am J Physiol. 1997;273:R1067–71. - PubMed
  62. Madu AJ, Ughasoro MD. Anaemia of chronic disease: an in-depth review. Med Princ Pr. 2017;26:1–9. - PubMed
  63. Yáñez A, Goodridge HS, Gozalbo D, Gil ML. TLRs control hematopoiesis during infection. Eur J Immunol. 2013;43:2526–33. - PubMed
  64. Garred P, Genster N, Pilely K, Bayarri-Olmos R, Rosbjerg A, Ma YJ, et al. A journey through the lectin pathway of complement-MBL and beyond. Immunol Rev. 2016;274:74–97. - PubMed
  65. Burberry A, Zeng MY, Ding L, Wicks I, Inohara N, Morrison SJ, et al. Infection mobilizes hematopoietic stem cells through cooperative NOD-like receptor and Toll-like receptor signaling. Cell Host Microbe. 2014;15:779–91. - PubMed
  66. Kelley N, Jeltema D, Duan Y, He Y. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation. Int J Mol Sci. 2019;20:3328. - PubMed
  67. Man SM, Kanneganti TD. Regulation of inflammasome activation. Immunol Rev. 2015;265:6–21. - PubMed
  68. Lamkanfi M, Kanneganti TD. Nlrp3: an immune sensor of cellular stress and infection. Int J Biochem Cell Biol. 2010;42:792–5. - PubMed
  69. Hu B, Jin CH, Li HB, Tong J, Ouyang X, Cetinbas NM, et al. The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury. Science 2016;354:765–8. - PubMed
  70. Esplin BL, Shimazu T, Welner RS, Garrett KP, Nie L, Zhang Q, et al. Chronic exposure to a TLR ligand injures hematopoietic stem cells. J Immunol. 2011;186:5367–75. - PubMed
  71. Zhao Y, Ling F, Wang HC, Sun XH. Chronic TLR signaling impairs the long-term repopulating potential of hematopoietic stem cells of wild type but not Id1 deficient mice. PLoS ONE. 2013;8:e55552. - PubMed
  72. Megías J, Yáñez A, Moriano S, O’Connor JE, Gozalbo D, Gil ML. Direct Toll-like receptor-mediated stimulation of hematopoietic stem and progenitor cells occurs in vivo and promotes differentiation toward macrophages. Stem Cells. 2012;30:1486–95. - PubMed
  73. Haggadone MD, Grailer JJ, Fattahi F, Zetoune FS, Ward PA. Bidirectional crosstalk between C5a receptors and the NLRP3 inflammasome in macrophages and monocytes. Mediators Inflamm. 2016;2016:1340156. - PubMed
  74. Ward PA, Fattahi F. New strategies for treatment of infectious sepsis. J Leukoc Biol. 2019;106:187–92. - PubMed
  75. Kim SY, Son M, Lee SE, Park IH, Kwak MS, Han M, et al. High-mobility group box 1-induced complement activation causes sterile inflammation. Front Immunol. 2018;9:705. - PubMed
  76. Minutoli L, Puzzolo D, Rinaldi M, Irrera N, Marini H, Arcoraci V, et al. ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia/reperfusion injury. Oxid Med Cell Longev. 2016;2016:2183026. - PubMed
  77. Ratajczak MZ, Adamiak M, Thapa A, Bujko K, Brzezniakiewicz-Janus K, Lenkiewicz AM. NLRP3 inflammasome couples purinergic signaling with activation of the complement cascade for the optimal release of cells from bone marrow. Leukemia 2019;33:815–25. - PubMed
  78. Baroja-Mazo A, Martín-Sánchez F, Gomez AI, Martínez CM, Amores-Iniesta J, Compan V, et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat Immunol. 2014;15:738–48. - PubMed
  79. Ratajczak MZ, Bujko K, Ciechanowicz A, Sielatycka K, Cymer M, Marlicz W, et al. SARS-CoV-2 entry receptor ACE2 is expressed on very small CD45 - PubMed
  80. Ropa J, Cooper S, Capitano ML, Van’t Hof W, Broxmeyer HE. Human hematopoietic stem, progenitor, and immune cells respond ex vivo to SARS-CoV-2 spike protein. Stem Cell Rev Rep. 2021;17:253–65. - PubMed
  81. Kucia M, Ratajczak J, Bujko K, Adamiak M, Ciechanowicz A, Chumak V, et al. An evidence that SARS-Cov-2/COVID-19 spike protein (SP) damages hematopoietic stem/progenitor cells in the mechanism of pyroptosis in Nlrp3 inflammasome-dependent manner. Leukemia 2021;35:3026–9. - PubMed
  82. Kovacs SB, Miao EA. Gasdermins: effectors of pyroptosis. Trends Cell Biol. 2017;27:673–84. - PubMed
  83. Hong F, Chen Y, Gao H, Shi J, Lu W, Fu C, et al. NLRP1 in bone marrow microenvironment controls hematopoietic reconstitution after transplantation. Transpl Cell Ther. 2021;S2666-6367:01098–8. - PubMed
  84. Snäkä T, Fasel N. Behind the Scenes: Nod-like receptor X1 controls inflammation and metabolism. Front Cell Infect Microbiol. 2020;10:609812. - PubMed
  85. Coutermrash-Ott S, Eden K, Allen IC. Beyond the inflammasome: regulatory NOD-like receptor modulation of the host immune response following virus exposure. J Gen Virol. 2016;97:825–38. - PubMed
  86. Massberg S, Schaerli P, Knezevic-Maramica I, Köllnberger M, Tubo N, Moseman EA, et al. Immunosurveillance by hematopoietic progenitor cells trafficking through blood, lymph, and peripheral tissues. Cell 2007;131:994–1008. - PubMed
  87. Mazo IB, Massberg S, von Andrian UH. Hematopoietic stem and progenitor cell trafficking. Trends Immunol. 2011;32:493–503. - PubMed
  88. Ratajczak MZ, Kim CH, Wojakowski W, Janowska-Wieczorek A, Kucia M, Ratajczak J. Innate immunity as orchestrator of stem cell mobilization. Leukemia 2010;24:1667–75. - PubMed
  89. Ratajczak MZ, Adamiak M, Bujko K, Thapa A, Pensato V, Kucia M, et al. Innate immunity orchestrates the mobilization and homing of hematopoietic stem/progenitor cells by engaging purinergic signaling-an update. Purinergic Signal. 2020;16:153–66. - PubMed
  90. Adamiak M, Lenkiewicz AM, Cymer M, Kucia M, Ratajczak J, Ratajczak MZ. Novel evidence that an alternative complement cascade pathway is involved in optimal mobilization of hematopoietic stem/progenitor cells in Nlrp3 inflammasome-dependent manner. Leukemia 2019;33:2967–70. - PubMed
  91. Lenkiewicz AM, Adamiak M, Thapa A, Bujko K, Pedziwiatr D, Abdel-Latif AK, et al. The Nlrp3 inflammasome orchestrates mobilization of bone marrow-residing stem cells into peripheral blood. Stem Cell Rev Rep. 2019;15:391–403. - PubMed
  92. Jankovic D, Ganesan J, Bscheider M, Stickel N, Weber FC, Guarda G, et al. The Nlrp3 inflammasome regulates acute graft-versus-host disease. J Exp Med. 2013;210:1899–910. - PubMed
  93. Buffone A, Anderson NR, Hammer DA. Migration against the direction of flow is LFA-1-dependent in human hematopoietic stem and progenitor cells. Cell Sci. 2018;131:jcs205575. - PubMed
  94. Yang L, Hu M, Lu Y, Han S, Wang J. Inflammasomes and the maintenance of hematopoietic homeostasis: new perspectives and opportunities. Molecules 2021;26:309. - PubMed
  95. Frame JM, Kubaczka C, Long TL, Esain V, Soto RA, Hachimi M, et al. Metabolic regulation of inflammasome activity controls embryonic hematopoietic stem and progenitor cell production. Dev Cell. 2020;55:133–49. - PubMed
  96. Kovtonyuk LV, Fritsch K, Feng X, Manz MG, Takizawa H. Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment. Front Immunol. 2016;7:502. - PubMed
  97. Zhao J, Ghimire A, Liesveld J. Marrow failure and aging: the role of “Inflammaging”. Best Pr Res Clin Haematol. 2021;34:101283. - PubMed
  98. Basiorka AA, McGraw KL, Eksioglu EA, Chen X, Johnson J, Zhang L, et al. The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype. Blood 2016;128:2960–75. - PubMed
  99. Lambert C, Wu Y, Aanei C. Bone marrow immunity and myelodysplasia. Front Oncol. 2016;6:172. - PubMed
  100. Mantel CR, O’Leary HA, Chitteti BR, Huang X, Cooper S, Hangoc G, et al. Enhancing hematopoietic stem cell transplantation efficacy by mitigating oxygen shock. Cell 2015;161:1553–65. - PubMed
  101. Capitano ML, Mohamad SF, Cooper S, Guo B, Huang X, Gunawan AM, et al. Mitigating oxygen stress enhances aged mouse hematopoietic stem cell numbers and function. J Clin Invest. 2021;131:e140177. - PubMed

Publication Types

Grant support